×
About 37,534 results

ALLMedicine™ Pulmonary Hypertension Center

Research & Reviews  18,235 results

Transverse sinus dural arteriovenous fistula: a reversible cause of severe pulmonary hy...
https://doi.org/10.1136/bcr-2020-239544
BMJ Case Reports; Jordan L, Rodgers N et. al.

Feb 23rd, 2021 - Transverse sinus dural arteriovenous fistula: a reversible cause of severe pulmonary hypertension in an extremely premature infant.|2021|Jordan L,Rodgers N,Roberts KD,|

A more effective alternative to the 6-minute walk test for the assessment of functional...
https://doi.org/10.23736/S1973-9087.21.06561-8
European Journal of Physical and Rehabilitation Medicine; Marsico A, Dal Corso S et. al.

Feb 23rd, 2021 - The prognosis of Pulmonary Hypertension (PH) is directly correlated with the functional capacity (FC). The most common FC test is the 6-Minute Walk Test (6MWT), however, there is evidence to suggest that the 6MWT does not reflect the real FC in PH...

Perioperative management of patients with pulmonary hypertension undergoing non-cardiot...
https://doi.org/10.1016/j.bja.2021.01.005
British Journal of Anaesthesia; Price LC, Martinez G et. al.

Feb 22nd, 2021 - The risk of complications, including death, is substantially increased in patients with pulmonary hypertension (PH) undergoing anaesthesia for surgical procedures, especially in those with pulmonary arterial hypertension (PAH) and chronic thromboe...

Severe tricuspid regurgitation: prognostic role of right heart remodelling and pulmonar...
https://doi.org/10.1093/ehjci/jeab027
European Heart Journal Cardiovascular Imaging; Schneider M, König A et. al.

Feb 22nd, 2021 - Left heart diseases (LHDs) are the main driving forces for the development of functional tricuspid regurgitation (TR). Therefore, in most cases, the true prognostic value of TR remains concealed by concomitant LHD. This study aimed to analyse righ...

see more →

Guidelines  61 results

Under Pressure: An Update on Pulmonary Hypertension
https://www.the-rheumatologist.org/article/under-pressure-an-update-on-pulmonary-hypertension/
The Rheumatologist; Liebowitz J.

Nov 8th, 2020 - In patients with connective tissue diseases, such as systemic sclerosis (SSc), pulmonary hypertension (PH) remains one of the leading causes of morbidity and mortality. In her lecture on Friday, Nov. 6, Pulmonary Hypertension: An Update, Mardi Gom...

Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 18th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...

Canadian Cardiovascular Society/Canadian Thoracic Society Position Statement on Pulmona...
https://doi.org/10.1016/j.cjca.2019.11.041
The Canadian Journal of Cardiology; Hirani N, Brunner NW et. al.

Jul 19th, 2020 - The landscape of pulmonary hypertension (PH) has changed significantly since the last Canadian Cardiovascular Society/Canadian Thoracic Society position statement in 2005. Since then, advances in our understanding of the pathophysiology of PH and ...

2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary ...
https://doi.org/10.1016/j.healun.2019.06.022
The Journal of Heart and Lung Transplantation : the Offic... Hansmann G, Koestenberger M et. al.

Sep 9th, 2019 - The European Pediatric Pulmonary Vascular Disease Network is a registered, non-profit organization that strives to define and develop effective, innovative diagnostic methods and treatment options in all forms of pediatric pulmonary hypertensive v...

Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017).
https://doi.org/10.1253/circj.CJ-66-0158
Circulation Journal : Official Journal of the Japanese Ci... Fukuda K, Date H et. al.

Mar 11th, 2019 - Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017).|2019|Fukuda K,Date H,Doi S,Fukumoto Y,Fukushima N,|therapy,

see more →

Drugs  7 results see all →

Clinicaltrials.gov  18,625 results

Transverse sinus dural arteriovenous fistula: a reversible cause of severe pulmonary hy...
https://doi.org/10.1136/bcr-2020-239544
BMJ Case Reports; Jordan L, Rodgers N et. al.

Feb 23rd, 2021 - Transverse sinus dural arteriovenous fistula: a reversible cause of severe pulmonary hypertension in an extremely premature infant.|2021|Jordan L,Rodgers N,Roberts KD,|

A more effective alternative to the 6-minute walk test for the assessment of functional...
https://doi.org/10.23736/S1973-9087.21.06561-8
European Journal of Physical and Rehabilitation Medicine; Marsico A, Dal Corso S et. al.

Feb 23rd, 2021 - The prognosis of Pulmonary Hypertension (PH) is directly correlated with the functional capacity (FC). The most common FC test is the 6-Minute Walk Test (6MWT), however, there is evidence to suggest that the 6MWT does not reflect the real FC in PH...

Perioperative management of patients with pulmonary hypertension undergoing non-cardiot...
https://doi.org/10.1016/j.bja.2021.01.005
British Journal of Anaesthesia; Price LC, Martinez G et. al.

Feb 22nd, 2021 - The risk of complications, including death, is substantially increased in patients with pulmonary hypertension (PH) undergoing anaesthesia for surgical procedures, especially in those with pulmonary arterial hypertension (PAH) and chronic thromboe...

Severe tricuspid regurgitation: prognostic role of right heart remodelling and pulmonar...
https://doi.org/10.1093/ehjci/jeab027
European Heart Journal Cardiovascular Imaging; Schneider M, König A et. al.

Feb 22nd, 2021 - Left heart diseases (LHDs) are the main driving forces for the development of functional tricuspid regurgitation (TR). Therefore, in most cases, the true prognostic value of TR remains concealed by concomitant LHD. This study aimed to analyse righ...

see more →

News  567 results

Inhaled Treprostinil Improves Walking Distance in Patients With Pulmonary Hypertension
https://www.medscape.com/viewarticle/944054

Jan 13th, 2021 - NEW YORK (Reuters Health) - Frequent daily inhalation treatment with the United Therapeutics drug treprostinil significantly increased the six-minute walking distance of people whose interstitial lung disease left them with pulmonary hypertension,...

Under Pressure: An Update on Pulmonary Hypertension
https://www.the-rheumatologist.org/article/under-pressure-an-update-on-pulmonary-hypertension/
The Rheumatologist; Liebowitz J.

Nov 8th, 2020 - In patients with connective tissue diseases, such as systemic sclerosis (SSc), pulmonary hypertension (PH) remains one of the leading causes of morbidity and mortality. In her lecture on Friday, Nov. 6, Pulmonary Hypertension: An Update, Mardi Gom...

Levosimendan Hints at Potential Benefit in Unusual Form of Heart Failure
https://www.staging.medscape.com/viewarticle/938671

Oct 5th, 2020 - An inotropic and vasodilating drug with few clinical-trial victories in heart failure (HF) or other low-cardiac-output conditions showed some limited success in a specific subtype of HF with preserved ejection fraction (HFpEF). Patients with pulmo...

Levosimendan Hints at Potential Benefit in Unusual Form of Heart Failure
https://www.medscape.com/viewarticle/938671

Oct 5th, 2020 - An inotropic and vasodilating drug with few clinical-trial victories in heart failure (HF) or other low-cardiac-output conditions showed some limited success in a specific subtype of HF with preserved ejection fraction (HFpEF). Patients with pulmo...

Treprostinil Improves Walk Distance in Pulmonary Hypertension
https://www.medscape.com/viewarticle/933674

Jul 8th, 2020 - Patients with interstitial lung disease–associated pulmonary hypertension who were treated with inhaled treprostinil (Tyvaso) had significantly greater improvement in exercise capacity over 16 weeks, compared with patients who used a placebo inhal...

see more →

Patient Education  39 results see all →